Between a Rock and a Hard Place: How to Use Antithrombotics in Patients Undergoing Transcatheter Aortic Valve Replacement
Transcatheter aortic valve replacement (TAVR) has become the preferred method for management of severe aortic stenosis in patients who are at high and intermediate surgical risk, and has recently gained approval from the Food and Drug Administration in the US for use in patients at low risk for surg...
Main Authors: | Kelsey Grossman, Mathew R Williams, Homam Ibrahim |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2020-02-01
|
Series: | US Cardiology Review |
Online Access: | https://www.uscjournal.com/articles/Antithrombotics-Transcatheter-Aortic-Valve-Replacement |
Similar Items
-
Antithrombotic Therapy Following Transcatheter Aortic Valve Replacement
by: Camille Granger, et al.
Published: (2022-04-01) -
Antithrombotic Management for Transcatheter Aortic Valve Implantation
by: Lina Ya’Qoub, et al.
Published: (2023-12-01) -
Risk of Bleeding after Transcatheter Aortic Valve Replacement: impact of Preoperative Antithrombotic Regimens
by: Monirah A Albabtain, et al.
Published: (2021-12-01) -
Antithrombotic Therapy After Transcatheter Aortic Valve Implantation
by: Leslie Marisol Lugo, et al.
Published: (2020-02-01) -
Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era
by: Luca Testa, et al.
Published: (2019-11-01)